Physician profile
Babak Tehranchi
NPI 1073503967
$2,117.74
in general payments reported to CMS, 2019-2025
8 companies · $408 in 2025
The $408 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.04 · 2020: $27.58 · 2021: $28.11 · 2022: $36.91 · 2023: $1,266 · 2024: $327 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Travel and Lodging: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.08 |
| Travel and Lodging | $919.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,082.79 | 2023 | Mitraclip |
| Abiomed | $670.07 | 2023-2025 | Impella |
| Boston Scientific Corporation | $124.05 | 2019-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $106.24 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $83.11 | 2021-2024 | Micra |
| Terumo Medical Corporation | $19.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.90 | 2022 | |
| Atricure, INC. | $14.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Tehranchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.